Gliclazide + Metformin Tablets(ER) bulk supplier for pharma manufacturers

Gliclazide + Metformin Tablets(Er) Suppliers & Bulk Manufacturers

Available Forms: Tablets(ER)

Available Strengths: Gliclazide 30 mg/60 mg + Metformin 500/1000 mg

Reference Brands: Glizid-M XR(US & EU)

Category: Diabetes

Gliclazide, a sulfonylurea, stimulates insulin secretion from pancreatic β-cells, while Metformin decreases hepatic glucose production and improves insulin sensitivity. This extended-release combination ensures stable blood glucose levels, reduces postprandial spikes, and improves patient adherence through once-daily dosing—offering synergistic control for type 2 diabetes with a lower risk of hypoglycemia.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Gliclazide + Metformin Extended-Release (ER) tablets are not FDA-approved in the United States but are widely authorized and marketed in the European Union under national procedures. The combination is indicated for managing type 2 diabetes mellitus in adults inadequately controlled on monotherapy. Products are registered under well-known brands like Diamicron MR + Metformin XR. European regulatory agencies mandate bioequivalence, stability, and pharmacodynamic evidence to ensure safety and efficacy. Although not listed in the U.S. Orange Book, this fixed-dose combination supports enhanced patient compliance and glycemic control. For sourcing support and B2B pharmaceutical trade, visit Pharmatradz.com.

Gliclazide + Metformin Tablets(Er) — third party manufacturing & bulk supply

Gliclazide + Metformin Tablets(Er) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Gliclazide + Metformin Tablets(Er) is supplied as Tablets(ER) — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Gliclazide + Metformin Tablets(Er) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Gliclazide + Metformin Tablets(Er) →

Back to Listing

Frequently Asked Questions

Gliclazide + Metformin Tablets(ER) is listed as Tablets(ER) in Gliclazide 30 mg/60 mg + Metformin 500/1000 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Gliclazide + Metformin Tablets(ER) is referenced against Glizid-M XR(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.